Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Circulating Biomarkers World Congress 2017

Phil Stephens's Biography

Phil Stephens, Chief Scientific Officer, Foundation Medicine

Dr. Stephens leads research and development at Foundation Medicine. Dr. Stephens is a world-renowned expert in next-generation sequencing and cancer genome analysis and has authored numerous publications in Nature, Nature Genetics, Nature Medicine, Cell and other high-profile journals. Since joining Foundation Medicine in early 2011 Dr Stephens has overseen the development of FoundationOneā„¢, and FoundationOneā„¢ Heme, comprehensive next generation sequencing diagnostic assays that accurately profiles the entire coding sequence of hundreds of cancer-related genes in the CLIA setting. Prior to joining Foundation Medicine, Dr. Stephens held various senior research positions during his 11-year tenure with the Cancer Genome Project at the Wellcome Trust Sanger Institute under the direction of Sir Professor Michael Stratton.

Phil Stephens Image

Will the Liquid Biopsy Ever Replace Solid Tumor Biopsies?

Tuesday, 21 March 2017 at 11:30

Add to Calendar ▼

Add to Calendar ▼2017-03-20 00:00:002017-03-21 00:00:00Europe/LondonCirculating Biomarkers World Congress 2017Circulating Biomarkers World Congress 2017 in Boston, USABoston,